Retinitis Pigmentosa - Research to Prevent Blindness.

The term retinitis pigmentosa (RP) refers to a group of hereditary diseases, all of which eventually result in severe vision loss. Some of the diseases in the RP family are Usher syndrome, Lebers congenital amaurosis, rod-cone disease, Bardet-Biedl syndrome, and Refsum disease. Approximately 100,000 people in the U.S. have RP. Symptoms usually surface during adolescence or young adulthood.

Mistakes in “proofreading” the genetic code of retinal cells is the cause of retinitis pigmentosa (RP), new research has found. The research, which was published in Nature Communications, was led by Professor Majlinda Lako at Newcastle University. The study investigated how the form of inherited blindness, RP, is caused by genetic defects in splicing factors.

Medindia provides you with the latest news and research breakthroughs on Retinitis Pigmentosa. Please find 12 such items on this topic. Immune System to Slow Degenerative Retinitis Pigmentosa.

Retinitis Pigmentosa News and Research RSS Retinitis pigmentosa (RP) is the name given to a group of inherited eye diseases that affect the retina (the light-sensitive part of the eye).

Currently, the term retinitis pigmentosa is commonly used to refer to a group of related eye disorders responsible of inducing progressive vision loss in the patients. Retina, a layer constituted of the light-sensitive tissues lining the back of the eye, takes the brunt of this eye disease.

Retinitis Pigmentosa Treatments. While research continues, there is no cure for retinitis pigmentosa. Your ophthalmologist will be able to talk you through anything that might help ease symptoms. Living with RP. Once diagnosed with retinitis pigmentosa, there will be a team of professionals and organisations to help you manage any vision loss and the impact it might have on your life. This may.

Figure 4: Genes and their relative contribution to retinitis pigmentosa Causal genes and their contributions to (A) autosomal-recessive disease (ARRP), including Usher’s and Bardet-Biedl (BBS) syndromes, (B) autosomal-dominant disease, and (C) X-linked disease. About 40% of cases are due to genes that are as yet undiscovered. In A, these cases are represented by three pie slices named.

Retinitis pigmentosa (RP) is the name given to a group of inherited eye conditions called retinal dystrophies. A retinal dystrophy such as RP affects the retina at the back of your eye and, over time, stops it from working. This means that RP causes gradual but permanent changes that reduce your vision. How much of your vision is lost, how quickly this happens and your age when it begins.

Research for a new treatment for retinitis pigmentosa (RP), a genetic disease affecting an average of one person every 3,500-5,000 is currently being carried out in Italy. This line of investigation originates from the research of Rita Levi Montalcini, winner of the 1986 Nobel Prize for Medicine, into the identification of nerve growth factors.

Retinitis pigmentosa is a group of hereditary progressive blinding diseases with variable clinical presentations. One form of the disease, autosomal dominant retinitis pigmentosa (ADRP), was linked to a mutation in the gene for rhodopsin. More than 70 different rhodopsin gene mutations have been reported in patients with ADRP. The mutations.

Gene therapy research. Underscoring the importance of genetic testing. Our goal at aSharedVision is to help the inherited retinal disease (IRD) community understand the field of gene therapy research and why it is more important than ever to get genetically tested.